Sokal Risk Score Is Superior to Hasford and EUTOS in Determining Survival Outcomes for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients

被引：0
|
作者：
Jiang, Brian Gabriel [1 ]
Kim, Dong-Wook [2 ]
Shih, Lee-Yung [3 ]
Chuah, Charles [4 ,5 ]
Than, Hein [4 ]
Kuo, Ming-Chung [6 ,7 ]
Li, HuiHua [8 ]
Allen, John Carson, Jr. [9 ]
See, Lionel K. Y. [10 ]
Yap, Bernard K. C. [10 ]
Goh, Yeow-Tee [4 ,10 ]
机构：
[1] Duke Univ, Sch Med, Durham, NC USA
[2] St Marys Hosp, Dept Haematol, Seoul, South Korea
[3] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp Linkou, Dept Hematol Oncol, Taipei, Taiwan
[4] Singapore Gen Hosp, Dept Hematol, Singapore, Singapore
[5] Duke NUS Grad Med Sch, Canc & Stem Cell Biol Signature Res Program, Singapore, Singapore
[6] Chang Gung Mem Hosp Linkou, Taoyuan, Taiwan
[7] Chang Gung Univ, Taoyuan, Taiwan
[8] Hlth Serv Res, Singapore, Singapore
[9] Duke NUS Grad Med Sch, Ctr Quantitat Med, Singapore, Singapore
[10] Duke NUS Grad Med Sch, Singapore, Singapore
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Optimal management of patients with newly diagnosed chronic phase chronic myeloid leukemia in 2007
    Mughal, Tariq
    Goldman, John M.
    CLINICAL LYMPHOMA & MYELOMA, 2007, 7 : S95 - S101
  • [22] Techniques for risk stratification of newly diagnosed patients with chronic myeloid leukemia
    Mitchell, Birgitta
    Deininger, Michael
    LEUKEMIA & LYMPHOMA, 2011, 52 : 4 - 11
  • [23] A CRITICAL COMPARISON OF SOKAL, EURO, AND EUTOS RISK SCORES IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH TYROSINE KINASE INHIBITORS
    Baccarani, M.
    Castagnetti, F.
    Gugliotta, G.
    Breccia, M.
    Iurlo, A.
    Levato, L.
    Abruzzese, E.
    Stagno, F.
    Bonifacio, M.
    Gozzini, A.
    Pregno, P.
    Binotto, G.
    Annunziata, M.
    Galieni, P.
    Fava, C.
    Bocchia, M.
    Gobbi, M.
    Russo, D.
    Specchia, G.
    Soverini, S.
    Alimena, G.
    Martinelli, G.
    Pane, F.
    Saglio, G.
    Rosti, G.
    HAEMATOLOGICA, 2015, 100 : 435 - 435
  • [24] A comparative study of Hasford score and Sokal index in prognostication of de novo chronic myeloid leukemia patients and a search for new prognostic markers
    Sinha, Swapan Kumar
    Sinha, Simanti
    Mandal, Palash Kumar
    Bhattacharyya, Nirmal Kumar
    Pandey, Abhigyan
    Gupta, Partha
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2013, 56 (03) : 216 - 220
  • [25] Phase 2 study of bosutinib in Japanese patients with newly diagnosed chronic phase chronic myeloid leukemia
    Masayuki Hino
    Itaru Matsumura
    Shin Fujisawa
    Kenichi Ishizawa
    Takaaki Ono
    Emiko Sakaida
    Naohiro Sekiguchi
    Yusuke Tanetsugu
    Kei Fukuhara
    Masayuki Ohkura
    Yuichiro Koide
    Naoto Takahashi
    International Journal of Hematology, 2020, 112 : 24 - 32
  • [26] Phase 2 study of bosutinib in Japanese patients with newly diagnosed chronic phase chronic myeloid leukemia
    Hino, Masayuki
    Matsumura, Itaru
    Fujisawa, Shin
    Ishizawa, Kenichi
    Ono, Takaaki
    Sakaida, Emiko
    Sekiguchi, Naohiro
    Tanetsugu, Yusuke
    Fukuhara, Kei
    Ohkura, Masayuki
    Koide, Yuichiro
    Takahashi, Naoto
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 112 (01) : 24 - 32
  • [27] Is the Sokal or EUTOS long-term survival (ELTS) score a better predictor of responses and outcomes in persons with chronic myeloid leukemia receiving tyrosine-kinase inhibitors?
    Zhang, Xiao-Shuai
    Gale, Robert Peter
    Huang, Xiao-Jun
    Jiang, Qian
    LEUKEMIA, 2022, 36 (02) : 482 - 491
  • [28] Phase 2 Study of Bosutinib in Japanese Patients with Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
    Takahashi, Naoto
    Matsumura, Itaru
    Fujisawa, Shin
    Ishizawa, Kenichi
    Ono, Takaaki
    Sakaida, Emiko
    Sekiguchi, Naohiro
    Tanetsugu, Yusuke
    Fukuhara, Kei
    Ohkura, Masayuki
    Koide, Yuichiro
    Hino, Masayuki
    BLOOD, 2019, 134
  • [29] Is the Eutos Long Term Survival (ELTS) Score a Useful Marker to Predict Outcome in Children with Newly Diagnosed Chronic Myeloid Leukemia (CML) in Chronic Phase (CP)? the Experience of the International Registry of Childhood CML
    Millot, Frederic
    De Keizer, Joe
    Metzler, Markus
    Suttorp, Meinolf
    Sedlacek, Petr
    Luesink, Maaike
    Cheng, Frankie W. T.
    Kalwak, Krzysztof
    Lausen, Birgitte
    Jakovljevic, Gordana
    De Moerloose, Barbara
    Dworzak, Michael
    Borisevich, Marina
    Yajima, Julia
    Ampatzidou, Mirella
    Farah, Roula
    Kaiserova, Emilia
    Guenes, Adalet Meral
    Baruchel, Andre
    BLOOD, 2023, 142
  • [30] Is the Sokal or EUTOS long-term survival (ELTS) score a better predictor of responses and outcomes in persons with chronic myeloid leukemia receiving tyrosine-kinase inhibitors?
    Xiao-Shuai Zhang
    Robert Peter Gale
    Xiao-Jun Huang
    Qian Jiang
    Leukemia, 2022, 36 : 482 - 491
12345